Poland· PL-100012069

Butapirazol

A phenylbutazone product containing phenylbutazonum, registered in Poland by GSK PSC Poland Sp. z o.o.. The same ATC class is registered in 2 of our 19 countries.

ATC M02AA01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedButapirazolATCM02AA01REGISTER NO.PL-100012069PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Phenylbutazone is registered in 2 of 19 countries.

Countries holding a registration under ATC M02AA01 (phenylbutazone), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Phenylbutazone · ATC M02AA01

2 / 19 countries

  • Finlandprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Phenylbutazonum
Manufacturer
GSK PSC Poland Sp. z o.o.
Country
Poland (PL)
ATC code
M02AA01
ATC class
Phenylbutazone
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990142910

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Phenylbutazone in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All phenylbutazone products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Denmark · Fenylbutazon Oba
  • United Kingdom (Northern Ireland) · Phenylbutazone Chemidex Pharma
  • Hungary · Phenylbutazon Richter
  • Romania · Fenilbutazonă Atb, Fenilbutazona Fiterman

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fe331ce6-b27a-47fe-978d-440b12a92ce9
GET /v1/drugs/fe331ce6-b27a-47fe-978d-440b12a92ce9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Maść",
  "source": "urpl",
  "strength": "50 mg/g",
  "packaging": "05909990142910 ¦ Rp ¦ 2185\n1 op. 30 g",
  "substance": "Phenylbutazonum 5 g",
  "common_name": "Phenylbutazonum",
  "pl_product_id": "100012069",
  "pozwolenie_nr": "01429",
  "auth_procedure": "NAR",
  "authorisation_validity": "2024-09-10"
}

See everything about phenylbutazone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.